AI Compliance for Healthcare: The Complete Guide

Why healthcare AI faces the most regulatory scrutiny

Healthcare AI makes decisions that can kill people. A diagnostic AI that misses a tumor, a drug interaction checker that misses a contraindication, or a triage algorithm that deprioritizes the wrong patient — the consequences of errors are immediate and severe. Regulators designed their frameworks with this in mind.

The EU AI Act classifies AI systems in all of the following as high-risk: diagnosis, treatment, patient monitoring, prediction, and management of medical conditions. If your AI system touches any clinical decision, it is high-risk under EU law.

EU AI Act requirements for healthcare AI

Healthcare AI falls under Annex III, Class 1 of the EU AI Act: "AI systems intended to be used as safety components in the management and operation of critical digital infrastructure..." and separately under the medical device regulation pathway.

For AI systems used in clinical settings, the EU AI Act requirements are extensive:

Risk management system (Article 9)

You must maintain an ongoing risk management process throughout the lifecycle of the AI system. This means identifying risks at design time, testing them before deployment, monitoring them in production, and updating your risk documentation when the system or its context changes.

Training data governance (Article 10)

Training data must be relevant, representative, error-free, and complete to the extent possible. For medical AI, this means your training dataset must accurately represent the patient population the AI will be used on — including diverse demographics, conditions, and edge cases. A model trained on predominantly male patients is not representative for female patients. This must be documented.

Technical documentation (Article 11)

Extensive documentation covering: general description and intended purpose, design specifications, architecture, training data description, validation results, accuracy metrics, known limitations, instructions for deployment, and post-market monitoring plan.

Logging (Article 12)

High-risk AI systems must automatically log events "sufficient to ensure that it is possible to assess compliance with the requirements... throughout the system's lifetime." For healthcare AI, this typically means logging each inference, the input data used, the output, the time, and the clinical context.

Human oversight (Article 14)

Perhaps the most impactful for clinical workflows: high-risk AI must be designed so that natural persons can "fully understand the capacities and limitations of the high-risk AI system and be able to duly monitor its operation." Clinicians must be able to override the AI, and the system must not present its output in a way that discourages clinical judgment. A diagnostic AI that presents a "definitive diagnosis" without confidence intervals or uncertainty estimates is not compliant.

Accuracy and robustness (Article 15)

The AI must be accurate, robust, and cybersecure. For medical AI, accuracy metrics must be validated on diverse datasets, and performance degradation over time must be monitored.

EU Medical Device Regulation (MDR) interaction

In the EU, AI software used in clinical decision support may qualify as a "software as medical device" (SaMD) under the EU MDR (Regulation 2017/745). If it does, you face MDR compliance in addition to the EU AI Act.

The EU AI Act and MDR are designed to work together. Article 6(3) of the EU AI Act states that AI systems already certified under MDR benefit from a presumption of conformity with some EU AI Act requirements for high-risk AI. However, conformity is not automatic — you need to verify the overlap.

US FDA Software as Medical Device (SaMD)

In the US, the FDA regulates "Software as a Medical Device" — software intended for one or more medical purposes that performs these purposes without being part of a hardware medical device. This includes AI diagnostic tools, clinical decision support software, and medical imaging AI.

FDA classification determines the regulatory pathway:

• Class I: Low risk — general controls only (e.g., administrative tools)
• Class II: Moderate risk — 510(k) clearance required (most clinical decision support)
• Class III: High risk — PMA (premarket approval) required (AI in life-support contexts)

The FDA's "Clinical Decision Support" guidance distinguishes between non-device CDS software (no FDA oversight) and device CDS software (FDA oversight). The key factor: does the software provide recommendations that a clinician cannot independently verify without understanding the underlying basis? If the AI black-boxes its reasoning to the point where a clinician cannot check it — it is likely a device.

HIPAA requirements for healthcare AI

HIPAA applies to covered entities (healthcare providers, health plans, clearinghouses) and their business associates. If you provide healthcare AI to these organizations and access protected health information (PHI), you are likely a business associate.

Key HIPAA requirements for healthcare AI developers:

• Business Associate Agreement (BAA): Required before accessing any PHI from a covered entity. Must be signed before deployment.
• Minimum necessary standard: You may only access the minimum PHI necessary to perform your function. If your AI does not need a patient's name to make its prediction, you should not have access to it.
• Security Rule: Technical safeguards for PHI — encryption at rest and in transit, access controls, audit logging, automatic logoff.
• Breach notification: Notify covered entity within 60 days of discovering a breach affecting PHI.

HIPAA does not currently have AI-specific provisions. Watch for HHS guidance on AI and PHI — the Office for Civil Rights has indicated this is a priority area.

Practical compliance roadmap for healthcare AI companies

If you are building (provider/developer)

1. Determine FDA classification for your product — engage FDA early via pre-submission meeting if you are unsure
2. Start EU AI Act technical documentation immediately — this takes 3–6 months for a mature healthcare AI product
3. Implement comprehensive logging from day one — retrofitting is painful
4. Design human oversight into the UX — the AI should present confidence levels, not certainties
5. Ensure training data is diverse and representative — document this explicitly
6. Sign BAAs with any healthcare organization that tests or deploys your product

If you are deploying (healthcare provider using AI tools)

1. Get the AI Act conformity documentation from your vendor — they must provide this
2. Ensure your vendor has signed a BAA if they handle PHI
3. Train clinical staff on AI limitations and the human oversight requirements
4. Document your own risk assessment of the AI tool in your clinical context
5. Establish a monitoring process for AI performance drift

Further reading

• Healthcare AI Compliance Checklist
• EU AI Act Annex III: Full List of High-Risk AI
• How to Do an AI Risk Assessment
• AI Compliance for Healthcare Industry